Lidocaine Hydrochloride 20 mg/mL
Lidocaine Hydrochloride · INJECTION, SOLUTION · Hospira, Inc.
Lidocaine Hydrochloride is a injection, solution containing lidocaine hydrochloride at 20 mg/mL, taken epidural. Manufactured by Hospira, Inc..
Key Facts
- Brand Name
- Lidocaine Hydrochloride
- Generic Name
- Lidocaine Hydrochloride
- NDC Code (Product)
0409-2066- Manufacturer
- Hospira, Inc.
- Strength
- 20 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL
- Marketing Status
- Application #
- ANDA040078
- Marketing Start
- 09/07/2005
Recall History
Akorn, Inc.
CGMP Deviations:
Teligent Pharma, Inc.
Superpotent Drug
Humco Holding Group, Inc
Microbial Contamination of Non-Sterile Product(s): The product was found to be contaminated with Bulkholderia sp.
Teligent Pharma, Inc.
CGMP Deviations: Lots recalled because they were manufactured at the same facility using the same components as the products that had cracked seals in caps that were found to be superpotent.
Aruba Aloe Balm N.V.
Chemical Contamination: Product manufactured with ethanol API that contains methanol
Akorn, Inc.
cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scope expanded to include other lots and products which potentially share the same root cause.
McKesson Corporation dba McKesson Drug Company
CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.
Teligent Pharma, Inc.
Superpotent Drug: Minimally superpotent
Baxter Healthcare Corp.
Lack of Assurance of Sterilty: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.
Fagron, Inc
Microbial contamination of non-sterile product.
Side Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Full Prescribing Information
Indications & Usage
INDICATIONS AND USAGE Lidocaine is indicated for the production of topical anesthesia of irritated or inflamed mucous membranes of the mouth and pharynx. It is also useful for reducing gagging during the taking of X-ray pictures and dental impressions.
Dosage & Administration
DOSAGE AND ADMINISTRATION Adult The maximum recommended single dose of lidocaine for healthy adults should be such that the dose of lidocaine does not exceed 4.5 mg/kg or 2 mg/lb body weight and does not in any case exceed a total of 300 mg. For symptomatic treatment of irritated or inflamed mucous membranes of the mouth and pharynx, the usual adult dose is 15 mL undiluted. For use in the mouth, the solution should be swished around in the mouth and spit out. For use in the pharynx, the undiluted solution should be gargled and may be swallowed. This dose should not be administered at intervals of less than three hours, and not more than eight doses should be given in a 24-hour period. The dosage should be adjusted commensurate with the patient’s age, weight and physical condition (see PRECAUTIONS ). Pediatric Care must be taken to ensure correct dosage in all pediatric patients as there have been cases of overdose due to inappropriate dosing. It is difficult to recommend a maximum dose of any drug for children since this varies as a function of age and weight. For children over 3 years of age who have a normal lean body mass and normal body development, the maximum dose is determin…
Warnings
WARNINGS EXCESSIVE DOSAGE, OR SHORT INTERVALS BETWEEN DOSES, CAN RESULT IN HIGH PLASMA LEVELS AND SERIOUS ADVERSE EFFECTS. PATIENTS SHOULD BE INSTRUCTED TO STRICTLY ADHERE TO THE RECOMMENDED DOSAGE AND ADMINISTRATION GUIDELINES AS SET FORTH IN THIS PACKAGE INSERT. THE MANAGEMENT OF SERIOUS ADVERSE REACTIONS MAY REQUIRE THE USE OF RESUSCITATIVE EQUIPMENT, OXYGEN, AND OTHER RESUSCITATIVE DRUGS. Lidocaine should be used with extreme caution if the mucosa in the area of application has been traumatized, since under such conditions there is the potential for rapid systemic absorption. Life-threatening and fatal events in infants and young children Postmarketing cases of seizures, cardiopulmonary arrest, and death in patients under the age of 3 years have been reported with use of Lidocaine Viscous 2% when it was not administered in strict adherence to the dosing and administration recommendations. In the setting of teething pain, Lidocaine Viscous 2% should generally not be used. For other conditions, the use of the product in patients less than 3 years of age should be limited to those situations where safer alternatives are not available or have been tried but failed. Methemoglobinemi…
Contraindications
CONTRAINDICATIONS Lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type, or to other components of the solution.
Drug Interactions
Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfasalazine, quinine
Adverse Reactions
ADVERSE REACTIONS Adverse experiences following the administration of lidocaine are similar in nature to those observed with other amide local anesthetic agents. These adverse experiences are, in general, dose-related and may result from high plasma levels caused by excessive dosage or rapid absorption, or may result from a hypersensitivity, idiosyncrasy or diminished tolerance on the part of the patient. Serious adverse experiences are generally systemic in nature. The following types are those most commonly reported: Central Nervous System CNS manifestations are excitatory and/or depressant and may be characterized by lightheadedness, nervousness, apprehension, euphoria, confusion, dizziness, drowsiness, tinnitus, blurred or double vision, vomiting, sensations of heat, cold or numbness, twitching, tremors, convulsions, unconsciousness, respiratory depression and arrest. The excitatory manifestations may be very brief or may not occur at all, in which case the first manifestation of toxicity may be drowsiness merging into unconsciousness and respiratory arrest. Drowsiness following the administration of lidocaine is usually an early sign of a high blood level of the drug and may o…
Frequently Asked Questions
What is Lidocaine Hydrochloride used for?
Lidocaine Hydrochloride contains Lidocaine Hydrochloride. It is a injection, solution taken epidural. Consult your doctor for specific uses.
Is Lidocaine Hydrochloride a controlled substance?
Lidocaine Hydrochloride is not classified as a controlled substance by the DEA.
What is the generic name for Lidocaine Hydrochloride?
The generic name for Lidocaine Hydrochloride is Lidocaine Hydrochloride. There are 8 other brand versions of Lidocaine Hydrochloride.
What is the NDC code for Lidocaine Hydrochloride 20 mg/mL?
The NDC (National Drug Code) for Lidocaine Hydrochloride 20 mg/mL is 0409-2066, listed by Hospira, Inc..
Other Lidocaine Brands
See all →- MAXOCAINE Lidocaine Hemp Oil Topical Analgesic40 mg/mL72188-188
- INSTA RELIEF DM40 mg/mL72465-600
- SUGAR BRANDS Rescue Pain Relief and Recovery40 mg/mL73313-075
- Meijer Pain Relieving Max Strength with Lavender Essential Oil Analgesic40 mg/mL79481-0019
- equate Burn Relief.5 g/100g79903-237
- POWERECT Max Power Male Delay10 mg/mL81923-198
- BLACK LABEL B NUMB5 g/100mL82617-103
- GOLD LABEL B NUMB.01 g/100mL82617-104
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)